Get the Stockscreener App
1.71
9.62%
0.15
After Hours:
1.75
0.04
+2.34%
Acumen Pharmaceuticals Inc Stock (ABOS) Forecast
The Acumen Pharmaceuticals Inc (ABOS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $5.677, representing a +231.99% increase from the current price of $1.71. The highest analyst price target is $5.6027, and the lowest is $5.7513.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ABOS Price Target
Average 2.859
(+67.19% Upside)
Is Acumen Pharmaceuticals Inc (ABOS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 40.56 | Neutral |
| STOCH(9,6) | 18.42 | Buy |
| STOCHRSI(14) | 78.41 | Neutral |
| MACD(12,26) | -0.1434 | Buy |
| ADX(14) | 20.80 | Neutral |
| William %R | -58.54 | Neutral |
| CCI(14) | -52.44 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.736
Sell
|
1.7159
Sell
|
| MA20 |
1.7855
Sell
|
1.8165
Sell
|
| MA50 |
2.205
Sell
|
2.0784
Sell
|
| MA100 |
2.384
Sell
|
2.3294
Sell
|
| MA200 |
2.7194
Sell
|
2.652
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ABOS could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on ABOS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 40.56 indicates that ABOS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 18.42 indicates that ABOS is oversold. This indicates that ABOS price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 78.41 indicates that ABOS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 20.8 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -52.44 indicates that ABOS is still oversold but not to an extreme extent.
Long-term ABOS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Acumen Pharmaceuticals Inc financial reports and earnings history, Acumen Pharmaceuticals Inc (ABOS) stock could reach $6.3484 by 2030, $56.07 by 2040 and $88.15 by 2050. See the projected annual prices until 2050 of the Acumen Pharmaceuticals Inc stock below:
- Acumen Pharmaceuticals Inc (ABOS) is expected to reach an average price of $22.12 in 2035, with a high prediction of $27.01 and a low estimate of $27.08. This indicates an $1,193% rise from the last recorded price of $1.71.
- Acumen Pharmaceuticals Inc (ABOS) stock is projected to chart a bullish course in 2040, with an average price target of $56.35, representing an $3,195% surge from its current level. The forecast ranges from a conservative $9.9092 to a sky-high $56.07.
- Our analysts predict Acumen Pharmaceuticals Inc (ABOS) to jump 2,283% by 2045, soaring from $40.83 to an average price of $40.74, potentially reaching $40.52. While $40.83 is the low estimate, the potential upside is significant.
- Acumen Pharmaceuticals Inc (ABOS) stock is expected to climb by 2050, reaching an average of $86.47, a $4,957% jump from its current level. However, a wide range of estimates exists, with high and low targets of $88.15 and $87.04, respectively, highlighting the market's uncertainty.
Acumen Pharmaceuticals Inc Stock (ABOS) Year by Year Forecast
Acumen Pharmaceuticals Inc Stock (ABOS) Price Forecast for 2025
Acumen Pharmaceuticals Inc Stock (ABOS) is expected to reach an average price of $2.859 in 2025, with a high prediction of $5.6158 and a low estimate of $0.1022. This indicates an +67.19% rise from the last recorded price of $1.71.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $5.4113 | $5.7513 | $5.6027 | +216.45% |
| March, 2025 | $5.8129 | $5.7542 | $5.5929 | +239.93% |
| April, 2025 | $5.7073 | $5.5644 | $5.6158 | +233.76% |
| May, 2025 | $2.7889 | $4.166 | $5.0302 | +63.09% |
| June, 2025 | $3.3304 | $2.9846 | $2.9704 | +94.76% |
| July, 2025 | $2.4949 | $2.6849 | $2.9354 | +45.90% |
| August, 2025 | $1.9936 | $2.4578 | $2.9336 | +16.58% |
| September, 2025 | $0.648 | $0.1022 | $2.7007 | -62.11% |
| October, 2025 | $1.3324 | $0.9309 | $1.0424 | -22.08% |
| November, 2025 | $1.574 | $1.8382 | $1.4082 | -7.95% |
| December, 2025 | $1.2884 | $1.5684 | $1.7128 | -24.65% |
Acumen Pharmaceuticals Inc Stock (ABOS) Price Forecast for 2026
The predicted value for Acumen Pharmaceuticals Inc (ABOS) in 2026 is set at an average of $3.0692. Estimates vary from a peak of $5.9577 to a trough of $0.1806, indicating an +79.48% surge from the present price of $1.71.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.08 | $1.12 | $0.67 | -36.84% |
| February, 2026 | $1.3215 | $1.3629 | $1.2115 | -22.72% |
| March, 2026 | $2.2631 | $1.9844 | $2.1202 | +32.34% |
| April, 2026 | $0.7475 | $2.4575 | $2.0596 | -56.29% |
| May, 2026 | $0.8791 | $0.7733 | $0.7091 | -48.59% |
| June, 2026 | $0.1606 | $0.1806 | $0.8423 | -90.61% |
| July, 2026 | $2.0349 | $0.5293 | $5.9577 | +19.00% |
| August, 2026 | $1.2234 | $1.1421 | $2.4391 | -28.46% |
| September, 2026 | $0.7489 | $0.4889 | $1.7705 | -56.20% |
| October, 2026 | $0.8126 | $0.304 | $0.731 | -52.48% |
| November, 2026 | $2.1342 | $1.1036 | $2.0242 | +24.81% |
| December, 2026 | $1.3886 | $1.6686 | $2.0171 | -18.79% |
Acumen Pharmaceuticals Inc Stock (ABOS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Acumen Pharmaceuticals Inc (ABOS) is $7.5436, with a high forecast of $15.07 and a low forecast of $0.0169. This indicates an +341.14% increase from the last price of $1.71.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0298 | $0.2552 | $1.0215 | -98.26% |
| February, 2027 | $0.3417 | $0.0169 | $0.864 | -80.02% |
| March, 2027 | $0.2638 | $0.0562 | $0.2638 | -84.57% |
| April, 2027 | $1.1123 | $0.3209 | $1.9652 | -34.95% |
| May, 2027 | $0.9007 | $0.3565 | $1.4365 | -47.33% |
| June, 2027 | $8.67 | $0.3178 | $8.39 | +407.02% |
| July, 2027 | $7.7931 | $5.9973 | $6.2508 | +355.74% |
| August, 2027 | $8.0962 | $7.4389 | $6.6362 | +373.46% |
| September, 2027 | $8.3351 | $8.5151 | $8.0535 | +387.43% |
| October, 2027 | $13.63 | $9.1409 | $11.38 | +696.97% |
| November, 2027 | $14.56 | $14.13 | $14.19 | +751.54% |
| December, 2027 | $15.69 | $14.72 | $15.07 | +817.56% |
Acumen Pharmaceuticals Inc Stock (ABOS) Price Forecast for 2028
In 2028, Acumen Pharmaceuticals Inc (ABOS) is projected to reach an average price of $11.18, with a high projection of $15.51 and a low estimate of $6.8486. This indicates an +553.64% rise from the last price of $1.71.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $15.02 | $15.59 | $15.51 | +778.56% |
| February, 2028 | $14.94 | $14.38 | $14.26 | +773.47% |
| March, 2028 | $15.38 | $14.50 | $15.30 | +799.14% |
| April, 2028 | $15.07 | $15.22 | $15.15 | +781.19% |
| May, 2028 | $14.82 | $14.90 | $14.89 | +766.51% |
| June, 2028 | $14.15 | $14.59 | $14.43 | +727.51% |
| July, 2028 | $11.15 | $11.84 | $12.76 | +552.25% |
| August, 2028 | $12.09 | $11.65 | $11.52 | +607.16% |
| September, 2028 | $9.6755 | $10.67 | $10.94 | +465.82% |
| October, 2028 | $6.1386 | $6.8486 | $10.83 | +258.98% |
| November, 2028 | $9.0275 | $8.0244 | $8.1475 | +427.92% |
| December, 2028 | $9.2506 | $9.1133 | $8.5648 | +440.97% |
Acumen Pharmaceuticals Inc Stock (ABOS) Price Forecast for 2029
The 2029 price forecast for Acumen Pharmaceuticals Inc Stock (ABOS) is $6.0442 on average, with a high prediction of $8.8925 and a low estimate of $3.1959. This represents an +253.46% increase from the previous price of $1.71.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.9595 | $9.2464 | $8.8925 | +423.95% |
| February, 2029 | $8.4526 | $8.5768 | $8.4453 | +394.30% |
| March, 2029 | $7.9357 | $7.8999 | $7.4764 | +364.08% |
| April, 2029 | $8.4288 | $8.0373 | $7.763 | +392.91% |
| May, 2029 | $8.6777 | $8.7177 | $8.5004 | +407.47% |
| June, 2029 | $6.3608 | $7.5708 | $8.1543 | +271.98% |
| July, 2029 | $6.3339 | $6.6938 | $6.5182 | +270.41% |
| August, 2029 | $5.8728 | $5.7613 | $6.0297 | +243.44% |
| September, 2029 | $3.0759 | $3.1959 | $3.8686 | +79.88% |
| October, 2029 | $3.8848 | $3.4317 | $3.5348 | +127.18% |
| November, 2029 | $4.9979 | $3.8206 | $3.9929 | +192.28% |
| December, 2029 | $5.531 | $5.1895 | $5.091 | +223.45% |
Acumen Pharmaceuticals Inc Stock (ABOS) Price Forecast for 2030
Acumen Pharmaceuticals Inc Stock (ABOS) is expected to reach an average price of $12.79 in 2030, with a high forecast of $23.57 and a low forecast of $1.9997. This signifies an +647.68% surge from the last price of $1.71.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.1399 | $6.4699 | $6.3484 | +259.06% |
| February, 2030 | $5.193 | $5.383 | $5.8807 | +203.69% |
| March, 2030 | $3.4861 | $3.7361 | $4.7738 | +103.87% |
| April, 2030 | $3.8692 | $3.5619 | $3.6192 | +126.27% |
| May, 2030 | $2.1681 | $2.9181 | $3.705 | +26.79% |
| June, 2030 | $1.7212 | $1.9997 | $1.6455 | +0.66% |
| July, 2030 | $2.2801 | $2.0628 | $2.1311 | +33.34% |
| August, 2030 | $18.31 | $2.0767 | $20.31 | +970.68% |
| September, 2030 | $17.90 | $17.75 | $17.04 | +946.98% |
| October, 2030 | $20.54 | $19.83 | $18.80 | +1,101% |
| November, 2030 | $18.48 | $19.69 | $19.35 | +980.78% |
| December, 2030 | $24.78 | $20.37 | $23.57 | +1,349% |
9.31%
0.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):